| scholarly article | Q13442814 |
| P2093 | author name string | Zheng Zhang | |
| Lifeng Wang | |||
| Fu-Sheng Wang | |||
| P2860 | cites work | MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib | Q24655048 |
| Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
| Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver | Q28593430 | ||
| miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting | Q29547487 | ||
| The role of microRNAs in liver cancer progression. | Q34543731 | ||
| miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. | Q34592976 | ||
| Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data | Q36505886 | ||
| MicroRNA profiling in cancer | Q37869934 | ||
| MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators. | Q39499110 | ||
| MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. | Q39528390 | ||
| High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. | Q45601546 | ||
| AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC | Q84563819 | ||
| P433 | issue | 2 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 103-104 | |
| P577 | publication date | 2011-10-10 | |
| P1433 | published in | Cellular and Molecular Immunology | Q26842256 |
| P1476 | title | The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC). | |
| P478 | volume | 9 |
| Q37729647 | A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinoma |
| Q35726813 | HIV-1 RNAs are Not Part of the Argonaute 2 Associated RNA Interference Pathway in Macrophages |
| Q89660982 | Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the RASSF1A Gene |
Search more.